These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37871286)

  • 21. Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway.
    Lou M; Iwatsuki M; Wu X; Zhang W; Matsumoto C; Baba H
    Ann Surg Oncol; 2024 May; 31(5):2983-2995. PubMed ID: 38006530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
    Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
    J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 20(R)-Panaxatriol enhances METTL3-mediated m
    Li Y; Luo B; Lin X; Bai D; Li L; Gao D; Li X; Zhong X; Wei Y; Yang L; Zhu X; Han L; Tian H; Zhang R; Wang P
    Phytomedicine; 2024 Jul; 130():155537. PubMed ID: 38823344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-κB pathway.
    Wen L; Sun W; Xia D; Wang Y; Li J; Yang S
    Neuroreport; 2022 Apr; 33(6):243-251. PubMed ID: 33165191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
    Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
    Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3/METTL14 Transactivation and m
    Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p.
    Li M; Wang Q; Zhang X; Yan N; Li X
    Cell Cycle; 2021 Jul; 20(13):1279-1294. PubMed ID: 34097560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3-dependent N
    Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The m
    Cheng M; Sheng L; Gao Q; Xiong Q; Zhang H; Wu M; Liang Y; Zhu F; Zhang Y; Zhang X; Yuan Q; Li Y
    Oncogene; 2019 May; 38(19):3667-3680. PubMed ID: 30659266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-κB pathway mediated NLRP3-ASC-Caspase1 inflammasome.
    Chen Y; Cao P; Xiao Z; Ruan Z
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109375. PubMed ID: 36461592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer.
    Xu X; Zhang P; Huang Y; Shi W; Mao J; Ma N; Kong L; Guo L; Liu J; Chen J; Lu R
    Cancer Sci; 2023 Jan; 114(1):105-114. PubMed ID: 36114749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m
    Ruan P; Wang S; Yang C; Huang X; Sun P; Tan A
    Cell Biol Toxicol; 2023 Aug; 39(4):1611-1626. PubMed ID: 35971034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m
    Zhang R; Chen P; Wang Y; Zeng Z; Yang H; Li M; Liu X; Yu W; Hou P
    Int J Biol Sci; 2024; 20(12):4750-4766. PubMed ID: 39309428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.
    Liu Q; Li M; Jiang L; Jiang R; Fu B
    Biochem Biophys Res Commun; 2019 Aug; 516(1):22-27. PubMed ID: 31186141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3 restrains papillary thyroid cancer progression via m
    He J; Zhou M; Yin J; Wan J; Chu J; Jia J; Sheng J; Wang C; Yin H; He F
    Mol Ther; 2021 May; 29(5):1821-1837. PubMed ID: 33484966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
    Feng Z; Li Q; Meng R; Yi B; Xu Q
    J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m
    Li SX; Yan W; Liu JP; Zhao YJ; Chen L
    Mol Immunol; 2021 Nov; 139():10-22. PubMed ID: 34450538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.